公司资料
Lantern PharmaAI 股价、新闻与催化剂
- 股票代码:
- LTRN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.71 USD (-11.40%)
收盘价
最后更新: 2026年9月17日
47.7M USD
市值
股价为何变动
截至 2026年9月17日，LTRN 下跌 11.4%，收于 $1.71。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Lantern Pharma is a technology-enabled oncology company focused on AI-assisted drug discovery and precision cancer medicine. Its platform combines computational tools with targeted oncology development.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Lantern sits at the intersection of AI and oncology biotechnology.
商业模式特征
The company depends on platform adoption, clinical progress, and the translation of AI-driven discovery into pipeline value.
生物医药行业定位
Lantern is a hybrid AI-oncology name whose stock depends on both platform credibility and drug-development progress.
未来催化剂
- Lantern’s catalysts are its AI-driven oncology discovery platform and any partnered or internal pipeline update. The company needs evidence that the platform is producing more than just tools.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。